Veracyte reported $164.03M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Agilent A:US $ 1484M 56M
Anika Therapeutics ANIK:US $ 90.98M 6.2M
Arrowhead Research ARWR:US $ 184.43M 141.55M
Bruker BRKR:US $ 573M 35.1M
Dicerna Pharmaceuticals DRNA:US $ 165.76M 55.45M
Exact Sciences EXAS:US $ 273.78M 89.94M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Illumina ILMN:US $ 1080M 3116M
Immunogen IMGN:US $ 245.76M 6.22M
Intrexon XON:US $ 41.73M 5.32M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Laboratory Of America LH:US $ 2036.5M 73.3M
Ligand Pharmaceuticals LGND:US $ 23.43M 1.57M
Luminex LMNX:US $ 271.56M 37.85M
Myriad Genetics MYGN:US $ 295.2M 176.8M
Rigel Pharmaceuticals RIGL:US $ 30.4M 54.42M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Siemens SIE:GR € 9545M 1133M
Thermo Fisher Scientific TMO:US $ 12027M 5004M
Veracyte VCYT:US $ 164.03M 163.52M
Waters WAT:US $ 655.19M 195.14M